Needham Initiates Coverage On InflaRx with Buy Rating, Announces Price Target of $8

Benzinga Newsdesk www.benzinga.com Neutral 66.4%

Neg 0% Neu 66.4% Pos 0%

Needham analyst Joseph Stringer initiates coverage on InflaRx (NASDAQ:IFRX) with a Buy rating and announces Price Target of $8.